Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

0
Player Avatar Rajhi (77.31) Submitted: 2/7/2012 9:39:48 AM : Outperform Start Price: $0.68 BPAX Score: +20.80

Should be above 1$

Report this Post Reply

Featured Broker Partners


Advertisement